ENLV

Enlivex Therapeutics Ltd.

1.34 USD
-0.05 (-3.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Enlivex Therapeutics Ltd. stock is up 3.88% since 30 days ago. The next earnings date is Aug 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 10 July’s closed higher than June.

About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state.